CWBR Research and Charts

CWBR - CohBar Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-16 (Delayed quote data 2025-01-06)

Last 0.41	Change ⇓ 0.00 (0.00%)	Volume 605
	Open 0.41	High 0.41	Low 0.41

8EMA (Daily) 0.46	40EMA (Daily) 0.49	50EMA (Daily) 0.50	STO (Daily) 21.176	MACD Hist (Daily) -0.033
8EMA (Weekly) 0.472	40EMA (Weekly) 0.64	50EMA (Weekly) 0.78	STO (Weekly) 52.157	MACD Hist (Weekly) 0.026


Company Profile
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drug such as CB4209 and CB4211, SHLP-6, SHLP-2 and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operation of the group is functioned through the region of United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.